Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P20020 (adenosine triphosphatase)
 3,299 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

We have reported that the maximal velocity of shortening and myofibrillar adenosine triphosphatase (ATPase) activity of antigen-sensitized airway smooth muscle are higher than that of nonsensitized airway smooth muscle (Kong, S. K., R. P. C. Shiu, and N. L. Stephens. J. Appl. Physiol. 60: 92-94, 1986). To extend these studies, we attempted to determine whether the increased myofibrillar ATPase activity from sensitized airway smooth muscle was associated with either a change in distribution of two myosin heavy chain isozymes or an increase in myosin light chain phosphorylation. Myosin heavy chain isozymes from both control and sensitized airway smooth muscle were separated by 4% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Gels were analyzed by densitometry, which indicated that isozyme band pattern of sensitized airway smooth muscle was not different from that of the control. The maximal levels of phosphorylated myosin light chain from whole cell homogenates of sensitized and control tracheal smooth muscles were 0.65 +/- 0.029 (n = 6) and 0.40 +/- 0.025 mol Pi/mol light chain (n = 6), respectively. The degree of phosphorylation of myosin light chain of sensitized airway smooth muscle was significantly higher than that of the control (P less than 0.05). This study also indicated that increased myofibrillar ATPase activity in sensitized tracheal smooth muscle was correlated with phosphorylation of myosin light chain.
 ...
PMID:Increased myosin phosphorylation in sensitized canine tracheal smooth muscle. 214 57

1. Myosin heavy chain (HC) and light chain (LC) isoforms are expressed in a tissue-specific and developmentally-regulated manner in human skeletal muscle. 2. At least seven myosin HC isoforms are expressed in skeletal muscle of the adult. 3. Histochemically-delineated fibre types (based on the stability of myofibrillar actomyosin adenosine triphosphatase activity) in limb muscles correlate with the myosin HC content. 4. Alterations in the phenotypic expression of myosin provides a mechanism of adaptation to stresses placed upon the muscle (e.g. increased and decreased usage).
 ...
PMID:Myosin polymorphism and differential expression in adult human skeletal muscle. 828 47

A histochemical assay for myofibrillar adenosine triphosphatase (mATPase) activity is routinely utilized in the delineation of fiber types in healthy human skeletal muscle. Each fiber type has a specific pH range of mATPase stability (activation). Outside of this pH range, mATPase activity is labile (inactivated), no reaction product is formed, and the fibers remain unstained. The aim of the present study was to carefully investigate the pH stability/lability of mATPase in postmortem muscles. To this end, vastus lateralis muscle samples were obtained approximately 0.5, 1, 2, 3, and 4 days after death, as well as control samples from a healthy young man and woman. Serial cross sections of the muscle samples were assayed for mATPase activity throughout preincubation pH ranges of 4.15-4.7 and 10.2-10.5 in increments of 0.05 pH units. Myosin heavy chain analysis (as well as a regression analysis comparing fiber type area and relative myosin heavy chain content) verified the mATPase-based fiber types. The pH ranges of mATPase stability/lability for the control samples were as previously reported, and support the use of preincubation pH values of 4.3, 4.6, and 10.4 for the delineation of fiber types in normal human muscle. For the postmortem samples, both quantitative and qualitative changes altered the pH ranges of mATPase activation/inactivation. Quantitative changes consisted of a time-dependent loss of mATPase activity that was inhibited in all fibers outside the pH range of 4.15-10.50. In addition, qualitative changes caused "shifts to the left" in mATPase stability within the fast fiber types (IIA and IIB). As such, complete inhibition of mATPase activity did not occur until preincubation at pH 4.45 and pH 4.30 for fiber types IIA and IIB, respectively. For the postmortem vastus lateralis muscle samples, optimal preincubation pH values for mATPase-based fiber type delineation were pH 4.30, 4.45, and 10.35. The reason for these qualitative changes in mATPase stability is not known. However, postmortem changes such as increased lactate production and marked acidification may play a role.
 ...
PMID:Postmortem alterations in the pH range of myofibrillar ATPase activation/inactivation. 1261 Jul 35

Hypothyroid heart displays a phenotype of cardioprotection against ischemia and this study investigated whether administration of dronedarone, an amiodarone-like compound that has been shown to preferentially antagonize thyroid hormone binding to thyroid hormone receptor alpha1 (TRalpha1), results in a similar effect. Dronedarone was given in Wistar rats (90 mg/kg, once daily (od) for 2 weeks) (DRON), while untreated animals served as controls (CONT). Hypothyroidism (HYPO) was induced by propylthiouracil administration. Isolated rat hearts were perfused in Langendorff mode and subjected to 20 minutes of zero-flow global ischemia (I) followed by 45 minutes of reperfusion (R). 3,5,3' Triiodothyronine remained unchanged while body weight and food intake were reduced. alpha-Myosin heavy chain (alpha-MHC) decreased in DRON while beta-myosin heavy chain (beta-MHC) and sarcoplasmic reticulum Ca2+ adenosine triphosphatase (ATPase) expression (SERCA) was similar to CONT. In HYPO, alpha-MHC and SERCA were decreased while beta-MHC was increased. Myocardial glycogen content was increased in both DRON and HYPO. In DRON, resting heart rate and contractility were reduced and ischemic contracture was significantly suppressed while postischemic left ventricular end-diastolic pressure and lactate dehydrogenase release (IU/L min) after I/R were significantly decreased. In conclusion, dronedarone treatment results in cardioprotection by selectively mimicking hypothyroidism. This is accompanied by a reduction in body weight because of the suppression of food intake. TRs might prove novel pharmacologic targets for the treatment of cardiovascular illnesses.
 ...
PMID:Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. 1568 16